title: Bilateral diffuse orbital myositis in a patient with relapsing ulcerative colitis.
abstract: Ophthalmic manifestations of inflammatory bowel disease are common, but orbital inflammatory disease is rare with most cases associated with Crohn disease. We describe the first case of bilateral, diffuse, orbital myositis associated with ulcerative colitis in a patient taking infliximab. Within 72 hours of intravenous methylprednisolone treatment, the orbital inflammation dramatically improved. After 8 weeks of prednisone, it completely resolved and has remained quiet for 13 months. This is only the third report of ulcerative colitis-associated orbital inflammatory disease.
authors.affiliation: School of Medicine, West Virginia University, Morgantown, West Virginia 26506, USA.
authors.forename: John
authors.initials: J
authors.lastname: Bennion
authors.forename: Matheson A
authors.initials: MA
authors.lastname: Harris
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Sivak-Callcott
authors.forename: John
authors.initials: J
authors.lastname: Nguyen
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009801:Oculomotor Muscles / Q000000981:diagnostic imaging / Q000473:pathology; D055622:Orbital Myositis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D012008:Recurrence; D014057:Tomography, X-Ray Computed
chemical_list: D000911:Antibodies, Monoclonal; D005938:Glucocorticoids; D000069285:Infliximab; D008775:Methylprednisolone